her symptoms began at 61 years it is well known that myastatia gravis may present in old age. Six other patients died during the follow up; some of thme had r rt respiratory failure. The period Of survival after the respiratory failure was 1 to 7 years witha n of 3 3years.
There were 3 survivors. One patient was admittod i failuire at the 24th week of Er~p~*ncy. The chid was severely yasthenic at birth and died after 18 hours of artificial ventilation of its lungs. During the puerperium there was a striking remission of the myasthenia and she, is now controlled with neostigmine but has not had any further respiratory distress. Another patient developed respiratory failure folHowing thymetomy but improved in a few days; six minths later she had a further brief episode but control was salfactory during the subsequent eight years. The third survivor had a single short episode of respiratory failure which Was attributed to overdosaw of drus and itre was no recurrence durWinthe next seven years.
None of the pa died during arti&ial respiration. It is wll known that sudden death occurs in patients with myasthenia gravis. Te deaths in this senes were sudden and not preceded by respiratory distress. It seems possi-ble that circutory factors were significnt. Two patients died following abdominal operaton and the effect oeostgmie is ofpossible imprtance in these. It has been shown that the use of neostigmine as a single-dose antidote to curare-type drugs in anesthesia for nonmyasthenic patients is associated with a higher incidefice of leakae from intefstnal anastomosis (Bell & Lewis 1968).
Myasthenic patipnts receive large doses ofneostigmine and often develop colic and other-intestinal symptoms which can be controlled with drugs of the atropine group. It is not unreasonable to ex-pect such bowel activity to have an advrs effect on a recent intestinal anastomosis.
After thymectomy the neostigmine requirement may change and it is important to avoid excessive dosage in the immediate post-operative phase.
Conclusion
Unless precipitated by pregnancy or thymectomy the onet of respiratory failue in a m patient is an unfavourable p ic sig. R current respiratory failure indicates a poor prognosis. The success of public health environmental control has led to the virtual elimination f lethal inftiou disease in Wester Europe and to a greatl increased impotance of cngeital malformations and dIg_enerive diseatis which are partly geetic. Although some diseases appear to be 'purey' environ ntal in origin and some 'purely' genetic, conmon disease is usually nmltifatorial. Autosomal recessive traits are, however, in th e a p also responsible for much diease and prM*bay fotal loss: all of us are probably heterozygotes for 3-5 lethal autosomal recessive traits.
In sickle cell disease we have almost the whole story, from the mutant DNA base representing the essential genetic change to the mode of clinical presentation. Thus to demonstrate a simple pattern of inheritance is to imply a relatively simple biochemical pathway and ultimate etiological clarification. However, most common diseases, including many congenital malformations and the so-called degenerative disorders, are multifactorially determined, implying the participation of a number of environmental factors and 'polygenes'. It is thought that individuals have more or less liability to diseases of this type but only develop clinical manifestations when their liability oversteps a threshold. Liability is made up of genetic predisposition and a number of (usually unknown) etiological agents in the environment and it is convenient to consider the distribution of liability towards a given disease in the population as being normally distributed.
The characteristic feature of diseases which are multifactorially determined is that the risk to children is more or less the same as for siblings and the risk to second-degree and more distant relatives falls off sharply. This is in contrast to autosomal recessive inheritance where, excluding consanguineous and chance mating to a heterozygous carrier, the risk is virtually confined to the siblings of the proband.
Genetic counselling involving diseases of multifactorial origin must be based upon empirical risk figures derived from data obtained in surveys of families in which the same disease occurs. When dealing with autosomal recessive disease the risk to each sibling is 1:4.
Eugenic considerations have little place in multifactorial and recessive conditions. For example: the common form of retinitis pigmentosa with or without deafness is inherited as an autosomal recessive. The frequency of affected individuals is something like 1 in 20,000 -not particularly common. Affected individuals are usually fertile and it is often asked if they should avoid the risk of passing on the gene. Unrecognized heterozygotes occur with a frequency of about 1 in 70 in the population (i.e. 300 times as often as cases of the disease) and it can be seen that whether or not individuals with the disease pass on the gene is numerically unimportant. Counselling should thus be based upon the risk that each offspring will have the disease (about 1 in 140 for nonconsanguineous matings), the prognosis and the likely future ability of the parent to cope with and provide for the children.
Autosomal dominant conditions of sufficient severity to require counselling are of course relatively rare. The genetic problem is apparently simple and on average half the offspring of affected individuals will inherit the mutant allele. It is, however, now obvious that phenotypically similar diseases may have quite different modes of genetic determination (genetic heterogeneity), while in some cases the disease may not be genetic in origin (phenocopy). Delay in expression of a mutant gene (e.g. Huntington's chorea), great variation in its expression (e.g. von Recklinghausen's disease) and new mutants (e.g. achondroplasia) combined with genetic heterogeneity and the existence of phenocopies, serve to complicate greatly the task of the genetic counsellor in dealing with autosomal dominant diseases.
Many similar problems arise with X-linked recessive traits. Because of small family size it is often difficult to decide whether or not an isolated case of Duchenne muscular dystrophy represents a new mutation with little risk to other members of the family. Enzyme estimations performed on the mother's serum will greatly help since it may be possible, if these tests are negative, to be 80 % certain that the child is carrying a new mutation.
Genetic counselling is thus primarily dependent upon precise diagnosis and upon accurate pedigree. New techniques for antenatal diagnosis of chromosomal anomalies and biochemical disorders and an increased ability to recognize carriers of recessive genes greatly improve the quality of genetic diagnosis.
In counselling, simple statements of risk are rarely sufficient. Clinical acumen is required to perceive the unspoken fears and feelings of guilt which are usually associated with inherited disease (sometimes confused by patients with venereal disease).
When there is a high risk of producing affected offspring patients often ask for specific advice. Although it is tempting to consider the problem in relatively eugenic terms, attempts to eliminate apparently deleterious genes from the human population, even if this were possible, must be regarded with suspicion. For example, the sickle cell gene, although nearly lethal in homozygotes, actually protects infants in areas where falciparum malaria is common. Such genes represent a part of the essential genetic variability which organisms need if they are to be equipped to resist environmental stress.
A Logical Approach to Otogenic Brain Abscess [Summary] by R T Johnson OBE FRCS (University Department ofNeurosurgery, Royal Infirmary, Manchester, M13 9 WL)
The mortality of brain abscesses has improved little since Sir William MacEwen moved triumphantly into the field ninety years ago. The validity of his figures has been questioned, but
